Journal
CANCER RESEARCH
Volume 67, Issue 7, Pages 3127-3134Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-06-3547
Keywords
-
Categories
Funding
- NATIONAL CANCER INSTITUTE [P30CA068485, R01CA116021, R01CA056704] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041943] Funding Source: NIH RePORTER
- NCI NIH HHS [R01 CA116021, P30 CA068485, CA56704, CA68485, CA116021, R01 CA116021-01, R01 CA116021-03, R01 CA116021-02] Funding Source: Medline
- NIAMS NIH HHS [P30 AR041943, 5P30 AR41943] Funding Source: Medline
- BLRD VA [IK6 BX005225] Funding Source: Medline
Ask authors/readers for more resources
Constitutive activation of nuclear factor-kappa B (NF-kappa B) has been directly implicated in tumorigenesis of various cancer types, including melanoma. Inhibitor of kappa B kinase (IKK) functions as a major mediator of NF-kappa B activation. Thus, development of an IKK-specific inhibitor has been a high priority, although it remains unclear whether systemic inhibition of IKK will provide therapeutic benefit. In this study, we show that inhibition of NF-kappa B activity in melanocytes that are persistently expressing an active H-Ras(V12) gene and are deficient in the tumor suppressors inhibitor A of cyclin-dependent kinase 4/alternative reading frame results in reduction of melanoma tumor growth in vivo. This effect is, at least in part, via regulation of NF-kappa B nuclear activation and ReIA phosphorylation. Based on this result, we developed a double hammerhead ribozyme long-term expression system to silence either IKK alpha or IKK beta. The ribozymes were placed in an EBV construct and delivered i.v. to nude mice bearing melanoma lesions, which developed after i.v. injection of H-Ras-transformed melanoma cells. Our in vivo data show that knockdown of endogenous IKK beta significantly reduces the growth of the melanoma lesions and knockdown of either IKK alpha or IKK beta prolongs the life span of immunocompetent mice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available